Skip to main content
Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
1.050
+0.040 (3.96%)
Nov 22, 2024, 4:00 PM EST - Market closed

Femasys Revenue

Femasys had revenue of $554.91K in the quarter ending September 30, 2024, with 127.09% growth. This brings the company's revenue in the last twelve months to $1.26M, up 15.33% year-over-year. In the year 2023, Femasys had annual revenue of $1.07M, down -11.13%.

Revenue (ttm)
$1.26M
Revenue Growth
+15.33%
P/S Ratio
18.25
Revenue / Employee
$37,078
Employees
34
Market Cap
23.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.07M-134.25K-11.13%
Dec 31, 20221.21M26.53K2.25%
Dec 31, 20211.18M141.77K13.66%
Dec 31, 20201.04M108.85K11.72%
Dec 31, 2019929.06K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spectral AI 27.26M
Bolt Biotherapeutics 9.78M
NeuroOne Medical Technologies 3.92M
Pieris Pharmaceuticals 1.35M
GlycoMimetics 10.00K
Revenue Rankings

FEMY News

More News